A detailed history of State Street Corp transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, State Street Corp holds 159,295 shares of ABEO stock, worth $906,388. This represents 0.0% of its overall portfolio holdings.

Number of Shares
159,295
Previous 161,895 1.61%
Holding current value
$906,388
Previous $686,000 46.65%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.12 - $6.32 $10,712 - $16,432
-2,600 Reduced 1.61%
159,295 $1.01 Million
Q2 2024

Aug 14, 2024

BUY
$3.17 - $8.05 $240,603 - $610,995
75,900 Added 88.26%
161,895 $686,000
Q1 2024

May 15, 2024

BUY
$4.07 - $8.68 $36,630 - $78,120
9,000 Added 11.69%
85,995 $623,000
Q4 2023

Feb 14, 2024

BUY
$3.71 - $5.14 $96,089 - $133,126
25,900 Added 50.69%
76,995 $385,000
Q2 2023

Aug 14, 2023

BUY
$2.76 - $5.27 $21,528 - $41,106
7,800 Added 18.02%
51,095 $205,000
Q1 2023

May 15, 2023

SELL
$2.25 - $3.27 $20,700 - $30,084
-9,200 Reduced 17.53%
43,295 $122,000
Q4 2022

Feb 14, 2023

BUY
$2.4 - $5.65 $89,760 - $211,310
37,400 Added 247.76%
52,495 $161,000
Q3 2022

Nov 15, 2022

BUY
$2.79 - $5.56 $42,115 - $83,928
15,095 New
15,095 $46,000

Others Institutions Holding ABEO

About ABEONA THERAPEUTICS INC.


  • Ticker ABEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,950,380
  • Market Cap $33.9M
  • Description
  • Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...
More about ABEO
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.